Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuQuest Bio is a San Diego-based biotechnology company focused on the discovery and development of novel small molecule therapeutics for oncology and immunology. The company leverages a proprietary drug discovery platform that integrates structural biology, computational chemistry, and high-throughput screening to identify 'molecular glues' and other innovative modalities. By targeting previously 'undruggable' proteins, NuQuest Bio aims to provide transformative treatments for patients with high unmet medical needs. The company is currently in the pre-clinical stage, advancing a pipeline of internal programs focused on solid tumors and inflammatory conditions. NuQuest Bio is led by a team of experienced drug hunters with a track record in structural biology and medicinal chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuQuest Bio.